• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与低水溶性药物相关的生物制药挑战——脂质体制剂的潜在影响。

Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.

作者信息

O'Driscoll C M, Griffin B T

机构信息

School of Pharmacy, University College Cork, College Road, Cork, Ireland.

出版信息

Adv Drug Deliv Rev. 2008 Mar 17;60(6):617-24. doi: 10.1016/j.addr.2007.10.012. Epub 2007 Nov 6.

DOI:10.1016/j.addr.2007.10.012
PMID:18155800
Abstract

The percentage of new chemical entities synthesised with low aqueous solubility and high therapeutic efficacy is growing, this presents major challenges for the drug delivery scientists. The role of physicochemical properties in identification of suitable drug candidates for oral lipid-based delivery systems is discussed. A knowledge of the interplay of physicochemical and biopharmaceutical drug properties with the physiological environment of the gastro-intestinal tract (GIT), as a prerequisite to successful formulation design, is reviewed. The importance of excipient selection with an emphasis on bioactive excipients is stressed. The need for more examples of in vitro-in vivo correlations as a means of maximizing the development potential and commercial future for lipid-based formulations, and, promoting confidence within the industry for these delivery systems is highlighted.

摘要

具有低水溶性和高治疗效果的新化学实体的合成比例正在增加,这给药物递送科学家带来了重大挑战。讨论了物理化学性质在确定适合口服脂质递送系统的候选药物中的作用。综述了物理化学和生物药剂学药物性质与胃肠道(GIT)生理环境之间相互作用的知识,这是成功进行制剂设计的先决条件。强调了辅料选择的重要性,重点是生物活性辅料。强调需要更多体外-体内相关性的实例,以此作为最大化脂质制剂的开发潜力和商业前景的一种手段,并增强业内对这些递送系统的信心。

相似文献

1
Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.与低水溶性药物相关的生物制药挑战——脂质体制剂的潜在影响。
Adv Drug Deliv Rev. 2008 Mar 17;60(6):617-24. doi: 10.1016/j.addr.2007.10.012. Epub 2007 Nov 6.
2
Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.用于药物研发的脂质辅料与给药系统:监管视角
Adv Drug Deliv Rev. 2008 Mar 17;60(6):768-77. doi: 10.1016/j.addr.2007.09.010. Epub 2007 Nov 12.
3
Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.用于口服给药的脂质递送系统的制剂:材料、方法和策略。
Adv Drug Deliv Rev. 2008 Mar 17;60(6):625-37. doi: 10.1016/j.addr.2007.10.010. Epub 2007 Nov 4.
4
Enhancing intestinal drug solubilisation using lipid-based delivery systems.使用基于脂质的递送系统增强肠道药物溶解
Adv Drug Deliv Rev. 2008 Mar 17;60(6):673-91. doi: 10.1016/j.addr.2007.10.014. Epub 2007 Nov 7.
5
Enhancement of gastrointestinal absorption of poorly water soluble drugs via lipid based systems.通过脂质体系统提高难溶性药物的胃肠道吸收。
Indian J Exp Biol. 2004 Nov;42(11):1056-65.
6
Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.通过体外动态脂解模型优化口服脂质体药物递送系统的选择,以提高难溶性药物的口服生物利用度。
J Control Release. 2008 Jul 2;129(1):1-10. doi: 10.1016/j.jconrel.2008.03.021. Epub 2008 Apr 1.
7
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.脂质及基于脂质的制剂:优化亲脂性药物的口服给药
Nat Rev Drug Discov. 2007 Mar;6(3):231-48. doi: 10.1038/nrd2197.
8
Lipid-based systems for the enhanced delivery of poorly water soluble drugs.用于改善难溶性药物递送的脂质基系统。
Adv Drug Deliv Rev. 2008 Mar 17;60(6):615-6. doi: 10.1016/j.addr.2007.10.009. Epub 2007 Nov 4.
9
Approaches for the development of solid and semi-solid lipid-based formulations.固体和半固体脂质基制剂的开发方法。
Adv Drug Deliv Rev. 2008 Mar 17;60(6):734-46. doi: 10.1016/j.addr.2007.09.006. Epub 2007 Nov 4.
10
Recent advances in intravenous delivery of poorly water-soluble compounds.近年来,在静脉内递送疏水性差的化合物方面取得了进展。
Expert Opin Drug Deliv. 2009 Dec;6(12):1261-82. doi: 10.1517/17425240903307423.

引用本文的文献

1
Submicron-oleogel particles for enhanced oral delivery of hydrophobic compounds: and proof of concept.用于增强疏水性化合物口服递送的亚微米油凝胶颗粒:概念验证
Mater Today Bio. 2025 Aug 18;34:102212. doi: 10.1016/j.mtbio.2025.102212. eCollection 2025 Oct.
2
Immune Modulation with Oral DNA/RNA Nanoparticles.口服DNA/RNA纳米颗粒的免疫调节
Pharmaceutics. 2025 May 4;17(5):609. doi: 10.3390/pharmaceutics17050609.
3
An Overview of Hypertension: Pathophysiology, Risk Factors, and Modern Management.高血压概述:病理生理学、危险因素及现代管理
Curr Hypertens Rev. 2025 Mar 6. doi: 10.2174/0115734021349254250224074832.
4
Ionic resorcinarenes as drug solubilization agents in water.离子型间苯二酚芳烃作为水中的药物增溶剂。
RSC Adv. 2024 Oct 28;14(46):34228-34238. doi: 10.1039/d4ra06682k. eCollection 2024 Oct 23.
5
Comparative Analysis of Chemical Descriptors by Machine Learning Reveals Atomistic Insights into Solute-Lipid Interactions.基于机器学习的化学描述符对比分析揭示了溶质-脂质相互作用的原子水平见解。
Mol Pharm. 2024 Jul 1;21(7):3343-3355. doi: 10.1021/acs.molpharmaceut.4c00080. Epub 2024 May 23.
6
Targeting the Gut: A Systematic Review of Specific Drug Nanocarriers.靶向肠道:特定药物纳米载体的系统评价
Pharmaceutics. 2024 Mar 21;16(3):431. doi: 10.3390/pharmaceutics16030431.
7
Solubility of Poorly Soluble Drugs in Phosphatidylcholine-Based Drug Delivery Systems: Comparison of the Loading Capacity in the Bulk Formulation and Its Dispersed State.难溶性药物在基于磷脂酰胆碱的药物递送系统中的溶解度:整体制剂及其分散状态下载药量的比较。
Pharmaceuticals (Basel). 2024 Mar 21;17(3):400. doi: 10.3390/ph17030400.
8
Exploring LIPIDs for their potential to improves bioavailability of lipophilic drugs candidates: A review.探索脂质提高亲脂性候选药物生物利用度的潜力:综述
Saudi Pharm J. 2023 Dec;31(12):101870. doi: 10.1016/j.jsps.2023.101870. Epub 2023 Nov 10.
9
Development of a Dosage form for a Photoswitchable Local Anesthetic Ethercaine.一种可光开关的局部麻醉药乙卡因剂型的研发。
Pharmaceuticals (Basel). 2023 Oct 2;16(10):1398. doi: 10.3390/ph16101398.
10
Solid Lipid Nanoparticles Containing Morin: Preparation, Characterization, and Ex Vivo Permeation Studies.载有桑色素的固体脂质纳米粒:制备、表征及体外渗透研究
Pharmaceutics. 2023 May 28;15(6):1605. doi: 10.3390/pharmaceutics15061605.